Cargando…

Acquired nasolacrimal duct obstruction: clinical and histological findings of 275 cases

BACKGROUND: Acquired nasolacrimal duct obstruction is a blockage of the lacrimal outflow system usually caused by local nonspecific inflammation of the lacrimal sac and the nasolacrimal duct. However, cases exist where the primary nasolacrimal system obstruction is caused by malignancies. Our aim wa...

Descripción completa

Detalles Bibliográficos
Autores principales: Makselis, Almantas, Petroska, Donatas, Kadziauskiene, Aiste, Jaruseviciene, Ruta, Ruzgys, Andrius, Cimbalas, Andrius, Besusparis, Justinas, Asoklis, Rimvydas S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8734260/
https://www.ncbi.nlm.nih.gov/pubmed/34986808
http://dx.doi.org/10.1186/s12886-021-02185-x
_version_ 1784627979768299520
author Makselis, Almantas
Petroska, Donatas
Kadziauskiene, Aiste
Jaruseviciene, Ruta
Ruzgys, Andrius
Cimbalas, Andrius
Besusparis, Justinas
Asoklis, Rimvydas S.
author_facet Makselis, Almantas
Petroska, Donatas
Kadziauskiene, Aiste
Jaruseviciene, Ruta
Ruzgys, Andrius
Cimbalas, Andrius
Besusparis, Justinas
Asoklis, Rimvydas S.
author_sort Makselis, Almantas
collection PubMed
description BACKGROUND: Acquired nasolacrimal duct obstruction is a blockage of the lacrimal outflow system usually caused by local nonspecific inflammation of the lacrimal sac and the nasolacrimal duct. However, cases exist where the primary nasolacrimal system obstruction is caused by malignancies. Our aim was to investigate lacrimal sac pathologies in patients with acquired nasolacrimal duct obstruction and compare their clinical manifestations. METHODS: This retrospective clinical study included 275 patients with acquired nasolacrimal duct obstruction who underwent external dacryocystorhinostomy and lacrimal sac biopsy. Cases were classified into tumor or nonspecific pathology groups and subdivided according to the level of inflammation. Histological and clinical data were analyzed. RESULTS: Three tumors (1.1%) (an adenoid cystic carcinoma, an eccrine spiradenoma and small B cell lymphoma) were diagnosed. Chronic nongranulomatous inflammation was the most common histological finding, corresponding to 194 cases (70.5%). The other 81 (29.5%) were subacute, acute forms of nongranulomatous inflammation, tumors and fibrosis cases. Epiphora with continuous purulent discharge was the most common clinical sign reported by 144 (52.4%) patients, and two (0.7%) patients had a palpable mass near the medial canthal tendon, which was identified as an eccrine spiradenoma and small B cell lymphoma. There was no significant difference in the clinical symptoms, duration or case history between the nonspecific pathology and tumor groups (p = 0.292). CONCLUSIONS: Chronic nongranulomatous inflammation of the lacrimal sac was the most common finding among acquired nasolacrimal duct obstruction cases. There were no associations between the histological findings and clinical presentation. The authors recommend a lacrimal sac biopsy only in cases when a tumor is clinically suspected.
format Online
Article
Text
id pubmed-8734260
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-87342602022-01-07 Acquired nasolacrimal duct obstruction: clinical and histological findings of 275 cases Makselis, Almantas Petroska, Donatas Kadziauskiene, Aiste Jaruseviciene, Ruta Ruzgys, Andrius Cimbalas, Andrius Besusparis, Justinas Asoklis, Rimvydas S. BMC Ophthalmol Research BACKGROUND: Acquired nasolacrimal duct obstruction is a blockage of the lacrimal outflow system usually caused by local nonspecific inflammation of the lacrimal sac and the nasolacrimal duct. However, cases exist where the primary nasolacrimal system obstruction is caused by malignancies. Our aim was to investigate lacrimal sac pathologies in patients with acquired nasolacrimal duct obstruction and compare their clinical manifestations. METHODS: This retrospective clinical study included 275 patients with acquired nasolacrimal duct obstruction who underwent external dacryocystorhinostomy and lacrimal sac biopsy. Cases were classified into tumor or nonspecific pathology groups and subdivided according to the level of inflammation. Histological and clinical data were analyzed. RESULTS: Three tumors (1.1%) (an adenoid cystic carcinoma, an eccrine spiradenoma and small B cell lymphoma) were diagnosed. Chronic nongranulomatous inflammation was the most common histological finding, corresponding to 194 cases (70.5%). The other 81 (29.5%) were subacute, acute forms of nongranulomatous inflammation, tumors and fibrosis cases. Epiphora with continuous purulent discharge was the most common clinical sign reported by 144 (52.4%) patients, and two (0.7%) patients had a palpable mass near the medial canthal tendon, which was identified as an eccrine spiradenoma and small B cell lymphoma. There was no significant difference in the clinical symptoms, duration or case history between the nonspecific pathology and tumor groups (p = 0.292). CONCLUSIONS: Chronic nongranulomatous inflammation of the lacrimal sac was the most common finding among acquired nasolacrimal duct obstruction cases. There were no associations between the histological findings and clinical presentation. The authors recommend a lacrimal sac biopsy only in cases when a tumor is clinically suspected. BioMed Central 2022-01-05 /pmc/articles/PMC8734260/ /pubmed/34986808 http://dx.doi.org/10.1186/s12886-021-02185-x Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Makselis, Almantas
Petroska, Donatas
Kadziauskiene, Aiste
Jaruseviciene, Ruta
Ruzgys, Andrius
Cimbalas, Andrius
Besusparis, Justinas
Asoklis, Rimvydas S.
Acquired nasolacrimal duct obstruction: clinical and histological findings of 275 cases
title Acquired nasolacrimal duct obstruction: clinical and histological findings of 275 cases
title_full Acquired nasolacrimal duct obstruction: clinical and histological findings of 275 cases
title_fullStr Acquired nasolacrimal duct obstruction: clinical and histological findings of 275 cases
title_full_unstemmed Acquired nasolacrimal duct obstruction: clinical and histological findings of 275 cases
title_short Acquired nasolacrimal duct obstruction: clinical and histological findings of 275 cases
title_sort acquired nasolacrimal duct obstruction: clinical and histological findings of 275 cases
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8734260/
https://www.ncbi.nlm.nih.gov/pubmed/34986808
http://dx.doi.org/10.1186/s12886-021-02185-x
work_keys_str_mv AT makselisalmantas acquirednasolacrimalductobstructionclinicalandhistologicalfindingsof275cases
AT petroskadonatas acquirednasolacrimalductobstructionclinicalandhistologicalfindingsof275cases
AT kadziauskieneaiste acquirednasolacrimalductobstructionclinicalandhistologicalfindingsof275cases
AT jarusevicieneruta acquirednasolacrimalductobstructionclinicalandhistologicalfindingsof275cases
AT ruzgysandrius acquirednasolacrimalductobstructionclinicalandhistologicalfindingsof275cases
AT cimbalasandrius acquirednasolacrimalductobstructionclinicalandhistologicalfindingsof275cases
AT besusparisjustinas acquirednasolacrimalductobstructionclinicalandhistologicalfindingsof275cases
AT asoklisrimvydass acquirednasolacrimalductobstructionclinicalandhistologicalfindingsof275cases